← Leaderboards
Adam Lyon Green
University Of Colorado Denver
$1,905,394
Attributed
$1,905,394
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $474.3K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,905,394 · 2
By mechanism
K08$957,960 · 1
R01$947,434 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Ronald J Sokol$193,385,254
- Nathan A Dahl$949,480
- David R Grosshans$9,101,858
- Issam A Awad$18,526,491
- Sally J Rogers$35,933,937
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsResistanceGliomaIn VitroPharmaceutical PreparationsRecurrenceChildhood GliomaEffective TherapyChildImproved OutcomeMolecularPathway InteractionsChildhoodRadiation TherapyAdultCell TypeClinical TrialsCombined Modality TherapyCell Culture TechniquesCell LineChemotherapyCellsBrain NeoplasmsSampling
Grant awards (7)
Determining the Origins and Vulnerabilities of Pediatric Treatment-Induced Gliomas$473,097
R01 · FY2025 · NS · contact PI
Determining the Origins and Vulnerabilities of Pediatric Treatment-Induced Gliomas$474,337
R01 · FY2024 · NS · contact PI
Translational Investigation of XPO1 Inhibition in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma$189,000
K08 · FY2021 · NS · contact PI
Translational Investigation of XPO1 Inhibition in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma$191,160
K08 · FY2020 · NS · contact PI
Translational Investigation of XPO1 Inhibition in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma$192,240
K08 · FY2019 · NS · contact PI
Translational Investigation of XPO1 Inhibition in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma$192,240
K08 · FY2018 · NS · contact PI
Translational Investigation of XPO1 Inhibition in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma$193,320
K08 · FY2017 · NS · contact PI